Biologic drugs are a newer treatment option for chronic rhinosinusitis with nasal polyps. They work differently from other treatments. Nasal polyps are small, noncancerous growths that develop in ...
NanoViricides, Inc. (NYSE Amer.: NNVC ) (the “Company”), a clinical stage global leader in broad-spectrum antiviral ...
As the name implies, cough is the signature symptom, and it can go on for weeks. Whooping cough can develop into a more ...
But, for the first time, injecting epinephrine isn’t the only option. A San Diego-based company, ARS Pharmaceuticals, has ...
The spray, sold under the brand Neffy, is a single-dose nasal spray and is approved in adults and children who weigh 66 ...
The rare, but potentially fatal, consequence is just one thing to be aware of when looking to clear your sinuses ...
Most pediatricians are aware of the more common causes of chronic cough, but sometimes unexpected cases come along that ...
The company has set high expectations for depemokimab, which it is also advancing in three other inflammatory diseases, including asthma.
The Biden administration calls government data showing a significant drop in overdose drug deaths “a major, major change.” ...
The U.S. Food and Drug Administration in 2019 approved intranasal esketamine to treat depression in adults. However, little data is available on the use of ketamine or esketamine to treat bipolar ...
Clesrovimab is an extended half-life RSV neutralizing antibody in development for all infants in their first RSV season and ...
The needles, however, can add to the trauma of an attack and make patients hesitant to inject the medicine or even keep it on ...